Rentokil Initial Plc Stock Revenue
| RTOKYDelisted Stock | USD 32.79 0.40 1.21% |
Rentokil Initial PLC fundamentals help investors to digest information that contributes to Rentokil Initial's financial success or failures. It also enables traders to predict the movement of Rentokil Pink Sheet. The fundamental analysis module provides a way to measure Rentokil Initial's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rentokil Initial pink sheet.
Rentokil |
Rentokil Initial PLC Company Revenue Analysis
Rentokil Initial's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Rentokil Initial Revenue | 2.96 B |
Most of Rentokil Initial's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rentokil Initial PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Rentokil Initial PLC reported 2.96 B of revenue. This is 15.49% lower than that of the Industrials sector and significantly higher than that of the Specialty Business Services industry. The revenue for all United States stocks is 68.66% higher than that of the company.
Rentokil Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rentokil Initial's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rentokil Initial could also be used in its relative valuation, which is a method of valuing Rentokil Initial by comparing valuation metrics of similar companies.Rentokil Initial is currently under evaluation in revenue category among its peers.
Rentokil Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 11.45 B | |||
| Shares Outstanding | 372.77 M | |||
| Shares Owned By Institutions | 0.84 % | |||
| Price To Earning | 37.07 X | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 2.96 B | |||
| Gross Profit | 2.37 B | |||
| EBITDA | 656.6 M | |||
| Net Income | 263.2 M | |||
| Cash And Equivalents | 2.37 B | |||
| Cash Per Share | 6.38 X | |||
| Total Debt | 1.26 B | |||
| Debt To Equity | 2.64 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 3.87 X | |||
| Cash Flow From Operations | 563.2 M | |||
| Earnings Per Share | 0.80 X | |||
| Price To Earnings To Growth | 1.43 X | |||
| Target Price | 13.46 | |||
| Number Of Employees | 46 K | |||
| Beta | 0.44 | |||
| Market Capitalization | 9.6 B | |||
| Total Asset | 4.32 B | |||
| Retained Earnings | 2.07 B | |||
| Working Capital | (196 M) | |||
| Current Asset | 593 M | |||
| Current Liabilities | 789 M | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.23 % | |||
| Net Asset | 4.32 B | |||
| Last Dividend Paid | 0.067 |
About Rentokil Initial Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rentokil Initial PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rentokil Initial using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rentokil Initial PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Rentokil Pink Sheet
If you are still planning to invest in Rentokil Initial PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rentokil Initial's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |